← Leaderboards
Jennifer Foulke-Abel
Johns Hopkins University
$3,003,244
Attributed
$3,003,244
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.7M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,395,540 · 5
By mechanism
P01$8,604,440 · 4
K01$791,100 · 1
Top collaborators
- James B Kaper3 shared
- James P. Nataro3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Mark Donowitz$42,405,980
- David A Sack$10,059,713
- Xinzhong Dong$16,603,888
- Julie Goeun In$1,622,142
- Christine Marie George$5,363,332
Others in their field
Other Emerging Leaders on “Enteral”
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Kathleen Maletic Neuzil · Emory University$27,014,427
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$18,128,059
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
EnteralCellsProductionEnterotoxinsIntestinesDiarrheal DiseaseInsightMonolayerResponseCytokineImmuneDiarrheaFunctional DisorderEnvironmentExtracellularIntentionAcuteIntestinal EpitheliumInflammationInflammatoryDisease OutbreaksCell TypeInnate Immune ResponseCyclic Amp
Grant awards (14)
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,122,332
P01 · FY2025 · AI
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors$374,547
P01 · FY2025 · AI · contact PI
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,130,811
P01 · FY2024 · AI
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors$561,075
P01 · FY2024 · AI · contact PI
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,139,153
P01 · FY2023 · AI
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors$461,361
P01 · FY2023 · AI · contact PI
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors$38,819
P01 · FY2023 · AI · contact PI
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors$424,459
P01 · FY2022 · AI · contact PI
A Human Enteroid Model of Cholera Toxin Pathophysiology$158,220
K01 · FY2022 · DK · contact PI
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors$351,883
P01 · FY2021 · AI · contact PI
A Human Enteroid Model of Cholera Toxin Pathophysiology$158,220
K01 · FY2021 · DK · contact PI
A Human Enteroid Model of Cholera Toxin Pathophysiology$158,220
K01 · FY2020 · DK · contact PI
A Human Enteroid Model of Cholera Toxin Pathophysiology$158,220
K01 · FY2019 · DK · contact PI
A Human Enteroid Model of Cholera Toxin Pathophysiology$158,220
K01 · FY2018 · DK · contact PI